๐Ÿ”ฌ ืขื™ืจื•ื™ Human Placental Extract IV โ€“ ื˜ื™ืคื•ืœ ืจื’ื ืจื˜ื™ื‘ื™ ืœืฉื™ืงื•ื ืจืงืžื•ืช, ืื ื˜ื™-ืื™ื™ื’'ื™ื ื’ ื•ื”ืชื—ื“ืฉื•ืช ืชืื™ืช

๐Ÿ“Œ ืฉื ื‘ืขื‘ืจื™ืช: ืชืžืฆื™ืช ืคืœืกื ื˜ื” ืื ื•ืฉื™ืช (ื ื’ื–ืจืช ืžืฉืœื™ื” ืื ื•ืฉื™ืช) | ๐Ÿ“Œ ืฉื ื‘ืื ื’ืœื™ืช: Human Placental Extract IV

ืชืžืฆื™ืช ืคืœืกื ื˜ื” ืื ื•ืฉื™ืช (HPE) ื”ื™ื ืชืžืฆื™ืช ื‘ื™ื•ืœื•ื’ื™ืช ืฉืžื•ืคืงืช ืžืฉืœื™ื™ืช ืื“ื ืœืื—ืจ ืœื™ื“ื”. ื”ืฉืœื™ื” ื”ื™ื ืื™ื‘ืจ ื–ืžื ื™ ื”ืžืชืคืชื— ื‘ืžื”ืœืš ื”ื”ื™ืจื™ื•ืŸ ื•ืžืกืคืง ืœืชื™ื ื•ืง ื—ืžืฆืŸ, ื—ื•ืžืจื™ ื”ื–ื ื” ื•ื”ื•ืจืžื•ื ื™ื ื—ื™ื•ื ื™ื™ื. ืชืžืฆื™ืช ื–ื• ืžื›ื™ืœื” ื—ืœื‘ื•ื ื™ื, ื’ื•ืจืžื™ ื’ื“ื™ืœื”, ืฆื™ื˜ื•ืงื™ื ื™ื ื•ื—ื•ืžืฆื•ืช ืืžื™ื ื• ืืฉืจ ืชื•ืžื›ื™ื ื‘ื”ืชื—ื“ืฉื•ืช ื”ืชืื™ื ื•ื‘ืฉื™ืงื•ื ืจืงืžื•ืช.

ืžื” ื”ื•ืคืš ืืช ื”ืฉืœื™ื” (ืคืœืกื ื˜ื”) ืœื›ืœื™ ืจื‘-ืขื•ืฆืžื” ื‘ื˜ื™ืคื•ืœื™ ืื ื˜ื™-ืื™ื™ื’'ื™ื ื’?
๐Ÿ”ฌ ื’ื•ืจืžื™ ื’ื“ื™ืœื” (Growth Factors):
โœ” ืชื•ืžื›ื™ื ื‘ื”ืชื—ื“ืฉื•ืช ืจืงืžื•ืช, ืžื–ืจื–ื™ื ืจื™ืคื•ื™ ืคืฆืขื™ื ื•ืžืกื™ื™ืขื™ื ื‘ื”ืคื—ืชืช ืงืžื˜ื™ื.
โœ” ืžืžืจื™ืฆื™ื ืืช ื™ื™ืฆื•ืจ ื”ืงื•ืœื’ืŸ ื•ื”ืืœืกื˜ื™ืŸ, ืฉืชื•ืจืžื™ื ืœืžื™ืฆื•ืง ื”ืขื•ืจ ื•ืœืžืจืื” ืฆืขื™ืจ ื™ื•ืชืจ.

๐Ÿ’Ž ื—ื•ืžืฆื•ืช ืืžื™ื ื• ื—ื™ื•ื ื™ื•ืช:
โœ” ืžืกืคืงื•ืช ื—ื•ืžืจื™ ื’ืœื ืœื‘ื ื™ื™ืช ื—ืœื‘ื•ื ื™ื ื‘ืขื•ืจ, ื‘ืจืงืžื•ืช ื—ื™ื‘ื•ืจ ื•ื‘ืฉืจื™ืจื™ื.
โœ” ืชื•ืžื›ื•ืช ื‘ื™ืฆื™ืจืช ืงื•ืœื’ืŸ ื•ืžืื™ืฆื•ืช ืจื™ืคื•ื™ ืชืื™ื ืคื’ื•ืขื™ื.

๐Ÿงฌ ื ื•ืงืœืื•ื˜ื™ื“ื™ื ื•-DNA ื—ื•ืคืฉื™:
โœ” ืžืกื™ื™ืขื™ื ื‘ืชื™ืงื•ืŸ ื•ืฉื›ืคื•ืœ ืชืื™ื, ืžืฉืคืจื™ื ืืช ื’ืžื™ืฉื•ืช ื”ืขื•ืจ ื•ืžืคื—ื™ืชื™ื ื ื–ืงื™ ื’ื™ืœ.

๐Ÿ›ก ื ื•ื’ื“ื™ ื—ืžืฆื•ืŸ (Antioxidants):
โœ” ืžืคื—ื™ืชื™ื ื ื–ืงื™ ื—ืžืฆื•ืŸ ืฉื ื’ืจืžื™ื ืžื—ืฉื™ืคื” ืœืจืขืœื ื™ื, ืงืจื™ื ืช UV ื•ื–ื™ื”ื•ื ืกื‘ื™ื‘ืชื™.
โœ” ืžืกื™ื™ืขื™ื ื‘ืฉื™ืคื•ืจ ื’ื•ื•ืŸ ื”ืขื•ืจ ื•ื‘ื”ืคื—ืชืช ื›ืชืžื™ ื’ื™ืœ.

๐Ÿ”ฅ ืื ื–ื™ืžื™ื ื•ื—ืœื‘ื•ื ื™ื ื™ื™ื—ื•ื“ื™ื™ื: (ืคืคื˜ื™ื“ื™ื ื‘ื™ื•ืืงื˜ื™ื‘ื™ื™ื:)

โœ” ืžืฉืชืชืคื™ื ื‘ืชื”ืœื™ื›ื™ ืชื™ืงื•ืŸ ืชืื™ื™ื ื•ืžืื™ืฆื™ื ืจื™ืคื•ื™ ืจืงืžื•ืช.
โœ” ืžื’ื‘ื™ืจื™ื ืืช ื™ื›ื•ืœืช ื”ื’ื•ืฃ ืœื”ื™ืœื—ื ื‘ื“ืœืงื•ืช ื›ืจื•ื ื™ื•ืช โ€“ ืื—ืช ื”ืกื™ื‘ื•ืช ื”ืžืจื›ื–ื™ื•ืช ืœื”ื–ื“ืงื ื•ืช ืžื•ืืฆืช.
โœ”ืคืคื˜ื™ื“ื™ื ื‘ื™ื•ืืงื˜ื™ื‘ื™ื™ื: ืžื•ื•ืกืชื™ื ืชื”ืœื™ื›ื™ื ื—ื™ืกื•ื ื™ื™ื ื•ื“ืœืงืชื™ื™ื ื‘ื’ื•ืฃ.

๐Ÿฉธ ืฉื™ืคื•ืจ ื–ืจื™ืžืช ื”ื“ื ื•ื‘ื ื™ื™ืช ื›ืœื™ ื“ื ื—ื“ืฉื™ื (ืื ื’ื™ื•ื’ื ื–ื”):
โœ” ื’ื•ืจืžื™ ืฆืžื™ื—ื” ื‘ืฉืœื™ื” ืžืกื™ื™ืขื™ื ืœื™ืฆื™ืจืช ื›ืœื™ ื“ื ื—ื“ืฉื™ื, ืชื•ืจืžื™ื ืœื”ื–ื ืช ื”ืขื•ืจ ื•ืžืงื ื™ื ืœื• ืžืจืื” ื—ื™ื•ื ื™.

๐Ÿ’ก ืžื“ื•ืข ืœื‘ื—ื•ืจ ื‘ืขื™ืจื•ื™ HPE?
ื‘ื ื™ื’ื•ื“ ืœืฉื™ืžื•ืฉื™ื ืงื•ืกืžื˜ื™ื™ื ืžืงื•ืžื™ื™ื (ื›ื’ื•ืŸ ืงืจืžื™ื ื•ืžืกื›ื•ืช), ืขื™ืจื•ื™ ืชื•ืš-ื•ืจื™ื“ื™ ืžืืคืฉืจ ืกืคื™ื’ื” ืžืขืจื›ืชื™ืช ืฉืœ ื”ืจื›ื™ื‘ื™ื ื”ืคืขื™ืœื™ื ื™ืฉื™ืจื•ืช ืœื–ืจื ื”ื“ื, ืฉื ื”ื ื™ื›ื•ืœื™ื ืœื”ืฉืคื™ืข ืขืœ ืžืขืจื›ื•ืช ืฉื•ื ื•ืช ื‘ื’ื•ืฃ ื•ืœืชืžื•ืš ื‘ืจื™ืคื•ื™ ืชืื™ืช ืขืžื•ืง.


โš•๏ธ ื™ืชืจื•ื ื•ืช ืจืคื•ืื™ื™ื ืฉืœ ืขื™ืจื•ื™ ืชืžืฆื™ืช ืคืœืกื ื˜ื” ืื ื•ืฉื™ืช

โœ” ื”ืชื—ื“ืฉื•ืช ื•ืฉื™ืงื•ื ืจืงืžื•ืช โ€“ ืชื•ืžืš ื‘ืจื™ืคื•ื™ ืขื•ืจ, ืฉืจื™ืจื™ื ื•ืจืงืžื•ืช ื—ื™ื‘ื•ืจ.
โœ” ืฉื™ืคื•ืจ ื‘ืจื™ืื•ืช ื”ืขื•ืจ โ€“ ืžืขื›ื‘ ืกื™ืžื ื™ ื”ื–ื“ืงื ื•ืช, ืžืžืจื™ืฅ ื™ื™ืฆื•ืจ ืงื•ืœื’ืŸ ื•ืžืฉืคืจ ืœื—ื•ืช ื•ื’ืžื™ืฉื•ืช ื”ืขื•ืจ.
โœ” ืชืžื™ื›ื” ื‘ืžืขืจื›ืช ื”ื—ื™ืกื•ืŸ โ€“ ืžื›ื™ืœ ืคืคื˜ื™ื“ื™ื ื•ื‘ื™ื•ืžื•ืœืงื•ืœื•ืช ืฉืžื—ื–ืงื™ื ืืช ื”ื”ื’ื ื” ื”ื—ื™ืกื•ื ื™ืช.
โœ” ืฉื™ืคื•ืจ ืื ืจื’ื™ื” ื•ืžืฆื‘ ืจื•ื— โ€“ ืžื›ื™ืœ ื—ื•ืžืจื™ื ื“ืžื•ื™ื™ ื”ื•ืจืžื•ื ื™ื ืฉื™ื›ื•ืœื™ื ืœืกื™ื™ืข ื‘ื•ื•ื™ืกื•ืช ืื ืจื’ื˜ื™ ื•ื‘ืื™ื–ื•ืŸ ืžืฆื‘ ื”ืจื•ื—.
โœ” ืฉื™ืคื•ืจ ื‘ืคื•ืจื™ื•ืช ื•ืชืžื™ื›ื” ื”ื•ืจืžื•ื ืœื™ืช โ€“ ืžืฉืžืฉ ื‘ืจืคื•ืื” ื”ืžืกื•ืจืชื™ืช ืœื—ื™ื–ื•ืง ืžืขืจื›ืช ื”ืจื‘ื™ื™ื” ื”ื ืฉื™ืช ื•ื”ื’ื‘ืจื™ืช.
โœ” ืชืžื™ื›ื” ื‘ืžืขืจื›ืช ื”ืขืฆื‘ื™ื โ€“ ืžื›ื™ืœ ื’ื•ืจืžื™ ื’ื“ื™ืœื” ื ื•ื™ืจื•ื ืœื™ื™ื ืฉืขืฉื•ื™ื™ื ืœืฉืคืจ ืืช ืชืคืงื•ื“ ื”ืžื•ื— ื•ืœื”ื’ืŸ ืžืคื ื™ ืžื—ืœื•ืช ื ื™ื•ื•ื ื™ื•ืช.


๐Ÿ’Š ืื™ื ื˜ืจืืงืฆื™ื•ืช ื•ื”ืชื ื’ืฉื•ื™ื•ืช

๐Ÿ”ด ืžื“ื›ืื™ ืžืขืจื›ืช ื—ื™ืกื•ืŸ (ื›ื’ื•ืŸ ืกื˜ืจื•ืื™ื“ื™ื, Methotrexate) โ€“ ืขืœื•ืœื™ื ืœืฉื‘ืฉ ืืช ืคืขื™ืœื•ืช ื’ื•ืจืžื™ ื”ื’ื“ื™ืœื” ื‘ืคืœืกื ื˜ื”.
๐Ÿ”ด ื˜ื™ืคื•ืœื™ื ื”ื•ืจืžื•ื ืœื™ื™ื (ื›ื’ื•ืŸ ื’ืœื•ืœื•ืช ืœืžื ื™ืขืช ื”ืจื™ื•ืŸ, HRT) โ€“ ื™ืฉ ืœื”ื™ื•ื•ืขืฅ ื‘ืจื•ืคื ืœื’ื‘ื™ ืฉื™ืœื•ื‘ HPE ืขื ื˜ื™ืคื•ืœื™ื ื”ื•ืจืžื•ื ืœื™ื™ื ืื—ืจื™ื.
๐Ÿ”ด ื˜ื™ืคื•ืœื™ ื›ื™ืžื•ืชืจืคื™ื” โ€“ ืขืœื•ืœื™ื ืœื”ื™ื•ืช ืื™ื ื˜ืจืืงืฆื™ื•ืช ืขื ืชื”ืœื™ื›ื™ ื”ื—ืœืžื” ื•ื”ืชื—ื“ืฉื•ืช ืชืื™ื.


๐Ÿ“… ืžืชื™ ืžื•ืžืœืฅ ืœืงื‘ืœ ืืช ื”ืขื™ืจื•ื™?

โœ” ื˜ื™ืคื•ืœื™ ืื ื˜ื™-ืื™ื™ื’'ื™ื ื’ ื•ื”ืฆืขืจืช ืขื•ืจ โ€“ ืœื ืฉื™ื ื•ื’ื‘ืจื™ื ื”ืžืขื•ื ื™ื™ื ื™ื ื‘ืฉื™ืคื•ืจ ืžืจืื” ื”ืขื•ืจ ื•ืžื ื™ืขืช ืงืžื˜ื™ื.
โœ” ืฉื™ืคื•ืจ ื‘ื™ืฆื•ืขื™ื ื’ื•ืคื ื™ื™ื ื•ื”ืชืื•ืฉืฉื•ืช โ€“ ืœืื ืฉื™ื ืคืขื™ืœื™ื ืคื™ื–ื™ืช ืื• ืกืคื•ืจื˜ืื™ื ื”ื–ืงื•ืงื™ื ืœืฉื™ืงื•ื ืฉืจื™ืจื™ื ืžื”ื™ืจ ื™ื•ืชืจ.
โœ” ืชืžื™ื›ื” ื‘ืคื•ืจื™ื•ืช ื•ื‘ืจื™ืื•ืช ื”ื•ืจืžื•ื ืœื™ืช โ€“ ืžืกื™ื™ืข ืœื ืฉื™ื ืขื ื—ื•ืกืจ ืื™ื–ื•ืŸ ื”ื•ืจืžื•ื ืœื™ ื•ืœื’ื‘ืจื™ื ืขื ื™ืจื™ื“ื” ื‘ื˜ืกื˜ื•ืกื˜ืจื•ืŸ.
โœ” ื—ื™ื–ื•ืง ืžืขืจื›ืช ื”ื—ื™ืกื•ืŸ โ€“ ืžืชืื™ื ืœืžืฆื‘ื™ ืชืฉื™ืฉื•ืช ื—ื™ืกื•ื ื™ืช, ื“ืœืงื•ืช ื›ืจื•ื ื™ื•ืช ืื• ืžื—ืœื•ืช ืื•ื˜ื•ืื™ืžื•ื ื™ื•ืช.
โœ” ื˜ื™ืคื•ืœ ืžืฉืœื™ื ืœืื—ืจ ื ื™ืชื•ื—ื™ื ืคืœืกื˜ื™ื™ื ืื• ื˜ื™ืคื•ืœื™ ืœื™ื™ื–ืจ โ€“ ืžืกื™ื™ืข ื‘ื”ืืฆืช ืชื”ืœื™ืš ื”ืจื™ืคื•ื™ ืฉืœ ื”ืขื•ืจ.


๐Ÿง‘โ€โš•๏ธ ืื•ืคืŸ ืžืชืŸ ื”ืชืจื•ืคื”, ืžื™ื ื•ืŸ ื•ืชื“ื™ืจื•ืช ื”ื ื˜ื™ืœื”

ืžื˜ืจื” ืจืคื•ืื™ืชืžื™ื ื•ืŸ ืžื•ืžืœืฅ (IV)ื ื•ื–ืœ ื“ื™ืœื•ืœ ืžื•ืžืœืฅืžืฉืš ื”ืขื™ืจื•ื™
ืื ื˜ื™-ืื™ื™ื’'ื™ื ื’ ื•ืฉื™ืงื•ื ืขื•ืจ2-4 ืž"ืœ ืชืžืฆื™ืช ืคืœืกื ื˜ื”250 ืž"ืœ ืกืœื™ื™ืŸ 0.9%30-60 ื“ืงื•ืช
ืฉื™ืคื•ืจ ืื ืจื’ื™ื” ื•ืžืขืจื›ืช ื—ื™ืกื•ืŸ4-6 ืž"ืœ ืชืžืฆื™ืช ืคืœืกื ื˜ื”500 ืž"ืœ ืกืœื™ื™ืŸ45-90 ื“ืงื•ืช
ืชืžื™ื›ื” ื”ื•ืจืžื•ื ืœื™ืช ื•ืคื•ืจื™ื•ืช5-10 ืž"ืœ ืชืžืฆื™ืช ืคืœืกื ื˜ื”500 ืž"ืœ ื“ืงืกื˜ืจื•ื– 5%60-90 ื“ืงื•ืช


๐Ÿ“Š ื™ืขื™ืœื•ืช ื•ื”ื•ื›ื—ื•ืช ืžื—ืงืจื™ื•ืช

๐Ÿ“Œ ืžื—ืงืจ ืขืœ ืื ื˜ื™-ืื™ื™ื’'ื™ื ื’: ืชืžืฆื™ืช ืคืœืกื ื˜ื” ืฉื™ืคืจื” ืืช ื’ืžื™ืฉื•ืช ื”ืขื•ืจ ื•ื”ืคื—ื™ืชื” ืงืžื˜ื™ื ื‘ืงืจื‘ ื ืฉื™ื ื‘ื’ื™ืœืื™ 40+ ืชื•ืš 3 ื—ื•ื“ืฉื™ื. ืžื—ืงืจ ืฉื ืขืจืš ื‘ื™ืคืŸ ื”ืจืื” ื›ื™ ืฉื™ืžื•ืฉ ื‘ืชืžืฆื™ืช ืฉืœื™ื” ืžืกื™ื™ืข ื‘ื”ืคื—ืชืช ืงืžื˜ื™ื, ืฉื™ืคื•ืจ ืœื—ื•ืช ื”ืขื•ืจ ื•ื”ื‘ื”ืจืช ื›ืชืžื™ ืคื™ื’ืžื ื˜ืฆื™ื”.
๐Ÿ“Œ ื ื™ืกื•ื™ื™ื ืงืœื™ื ื™ื™ื ื”ืจืื• ืฉืชืžืฆื™ืช ืฉืœื™ื” ื™ื›ื•ืœื” ืœืชืžื•ืš ื‘ืžื˜ื‘ื•ืœื™ื–ื ื”ืชืื™ ื•ืœืฉืคืจ ืืช ื”ื”ืชืื•ืฉืฉื•ืช ืฉืœ ืชืื™ื ืคื’ื•ืขื™ื.
๐Ÿ“Œ ืžื—ืงืจื™ื ื ื•ืกืคื™ื ืžืฆื‘ื™ืขื™ื ืขืœ ื›ืš ืฉืฉื™ืžื•ืฉ ื‘ืชืžืฆื™ืช ืฉืœื™ื” ืขืฉื•ื™ ืœืฉืคืจ ืืช ืžืฆื‘ ื”ืจื•ื— ื•ื”ื—ื™ื•ื ื™ื•ืช, ื•ืœื”ืฉืคื™ืข ืœื˜ื•ื‘ื” ืขืœ ืชืคืงื•ื“ ืžืขืจื›ืช ื”ื—ื™ืกื•ืŸ.
๐Ÿ“Œ ืžื—ืงืจ ืขืœ ื‘ืจื™ืื•ืช ื—ื™ืกื•ื ื™ืช: ื ืžืฆื ื›ื™ ืขื™ืจื•ื™ HPE ืขืฉื•ื™ ืœืชืจื•ื ืœืฉื™ืคื•ืจ ื”ื”ืชืื•ืฉืฉื•ืช ืžืžื—ืœื•ืช ื›ืจื•ื ื™ื•ืช.
๐Ÿ“Œ ืžื—ืงืจ ืขืœ ืคื•ืจื™ื•ืช: ื ืฆืคืชื” ืขืœื™ื™ื” ื‘ืจืžื•ืช ื”ื•ืจืžื•ื ื™ื ื ืฉื™ื™ื ื•ืฉื™ืคื•ืจ ื‘ืžื“ื“ื™ ืคื•ืจื™ื•ืช ืืฆืœ ื ืฉื™ื ื•ื’ื‘ืจื™ื.


๐Ÿ’ฌ ืขื“ื•ื™ื•ืช ืฉืœ ืื ืฉื™ ืžืงืฆื•ืข ื•ืกืœื‘ืจื™ื˜ืื™ื

๐ŸŸข ืจื•ืคืื™ื ื‘ืชื—ื•ื ื”ืจืคื•ืื” ื”ืจื’ื ืจื˜ื™ื‘ื™ืช ืžืฉืชืžืฉื™ื ื‘-HPE ื›ื˜ื™ืคื•ืœ ืžืฉืœื™ื ืœืฉื™ืงื•ื ื’ื•ืฃ ืžืœื.
๐ŸŸข ื“ื™ื•ื•ื—ื™ื ืœื ืจืฉืžื™ื™ื ืžืฆื‘ื™ืขื™ื ืขืœ ื›ืš ืฉืกืœื‘ืจื™ื˜ืื™ื ื›ืžื• ืžื“ื•ื ื” ื•ืงื™ื ืงืจื“ืฉื™ืืŸ ืžืฉืชืžืฉื™ื ื‘ืขื™ืจื•ื™ HPE ื›ื—ืœืง ืžืฉื’ืจืช ื˜ื™ืคื•ืœื™ ื”ืื ื˜ื™-ืื™ื™ื’'ื™ื ื’ ืฉืœื”ื.


โš ๏ธ ืชื•ืคืขื•ืช ืœื•ื•ืื™ ื•ืื–ื”ืจื•ืช

๐Ÿ”ด ืชื™ืชื›ืŸ ืชื’ื•ื‘ื” ืืœืจื’ื™ืช โ€“ ืžื•ืžืœืฅ ืœื‘ืฆืข ื‘ื“ื™ืงื” ืœืคื ื™ ืžืชืŸ ืขื™ืจื•ื™ ืžืœื.
๐Ÿ”ด ื ืฉื™ื ื‘ื”ื™ืจื™ื•ืŸ ื•ืžื ื™ืงื•ืช โ€“ ืžื•ืžืœืฅ ืœื”ื™ืžื ืข ืขืงื‘ ื”ืฉืคืขื•ืช ื”ื•ืจืžื•ื ืœื™ื•ืช ืืคืฉืจื™ื•ืช.
๐Ÿ”ด ืชื™ืชื›ืŸ ืจื’ื™ืฉื•ืช ืงืœื” ื‘ืื–ื•ืจ ื”ื”ื–ืจืงื” ืื• ืชื—ื•ืฉืช ืขื™ื™ืคื•ืช ืงืœื” ืœืื—ืจ ื”ื˜ื™ืคื•ืœ.


๐Ÿ“œ ืจื’ื•ืœืฆื™ื” ื•ืื™ืฉื•ืจื™ื ืจืคื•ืื™ื™ื

โœ” ืžืื•ืฉืจ ื‘ื™ืคืŸ ื•ื‘ื“ืจื•ื ืงื•ืจื™ืื” ื›ื˜ื™ืคื•ืœ ืื ื˜ื™-ืื™ื™ื’'ื™ื ื’ ื•ืœืฉื™ืงื•ื ืจืงืžื•ืช.
โœ” ื‘ืžื“ื™ื ื•ืช ืžืกื•ื™ืžื•ืช, ื›ืžื• ืืจื”"ื‘, ื ื“ืจืฉ ืื™ืฉื•ืจ FDA ืœืฉื™ืžื•ืฉ ืจืคื•ืื™ ืกืคืฆื™ืคื™.
โœ” ื‘ื™ืฉืจืืœ? ื™ืฉ ืœื‘ื“ื•ืง ืขื ืžืฉืจื“ ื”ื‘ืจื™ืื•ืช ืืช ื”ืžืขืžื“ ื”ื—ื•ืงื™ ืฉืœ ืขื™ืจื•ื™ ื–ื”- ืื ื™ ื‘ืื•ืคืŸ ืื™ืฉื™ ื‘ื“ืงืช ื’ื ืœื’ื‘ื™ Human Placental Extract IV ื•ื’ื ืœื’ื‘ื™ ื—ื•ืžืฆื” ืืœืคื-ืœื™ืคื•ืื™ืช (ALA IV) ื•ืื™ืŸ ืื™ืฉื•ืจ ืจืฉืžื™!


๐Ÿ’ก ืขื™ืจื•ื™ ืชืžืฆื™ืช ืคืœืกื ื˜ื” ืื ื•ืฉื™ืช ืžืฆื™ืข ืฉื™ืœื•ื‘ ื™ื™ื—ื•ื“ื™ ืฉืœ ืฉื™ืงื•ื ืจืงืžื•ืช, ืื ื˜ื™-ืื™ื™ื’'ื™ื ื’ ื•ืชืžื™ื›ื” ื—ื™ืกื•ื ื™ืช โ€“ ืคืชืจื•ืŸ ื˜ื‘ืขื™ ืœื”ืชื—ื“ืฉื•ืช ื”ื’ื•ืฃ ืžื‘ืคื ื™ื!
๐Ÿ”ฅ ืจื•ืฆื” ืœื—ื•ื•ืช ืขื•ืจ ืงื•ืจืŸ, ื’ื•ืฃ ื—ื–ืง ื•ืžืœื ืื ืจื’ื™ื”? ืขื™ืจื•ื™ HPE ื™ื›ื•ืœ ืœื”ื™ื•ืช ื”ื‘ื—ื™ืจื” ื”ืžื•ืฉืœืžืช ืขื‘ื•ืจืš!

ื›ืชื™ื‘ืช ืชื’ื•ื‘ื”